1. Monitoring respiratory mechanics by oscillometry in COVID-19 patients receiving non-invasive respiratory support.
- Author
-
Torregiani C, Veneroni C, Confalonieri P, Citton GM, Salton F, Jaber M, Confalonieri M, and Dellaca' RL
- Subjects
- Adult, Aged, COVID-19 physiopathology, Feasibility Studies, Female, Humans, Italy, Male, Middle Aged, Pilot Projects, Respiratory Distress Syndrome physiopathology, Respiratory Distress Syndrome therapy, Respiratory Mechanics, Retrospective Studies, COVID-19 therapy, Lung physiopathology, Noninvasive Ventilation methods, Oscillometry methods, Respiratory Distress Syndrome virology
- Abstract
Background: Non-invasive ventilation (NIV) has been increasingly used in COVID-19 patients. The limited physiological monitoring and the unavailability of respiratory mechanic measures, usually obtainable during invasive ventilation, is a limitation of NIV for ARDS and COVID-19 patients management., Objectives: This pilot study was aimed to evaluate the feasibility of non-invasively monitoring respiratory mechanics by oscillometry in COVID-19 patients with moderate-severe acute respiratory distress syndrome (ARDS) receiving NIV., Method: 15 COVID-19 patients affected by moderate-severe ARDS at the RICU (Respiratory Intensive Care Unit) of the University hospital of Cattinara, Trieste, Italy were recruited. Patients underwent oscillometry tests during short periods of spontaneous breathing between NIV sessions., Results: Oscillometry proved to be feasible, reproducible and well-tolerated by patients. At admission, 8 of the 15 patients showed oscillometry parameters within the normal range which further slightly improved before discharge. At discharge, four patients had still abnormal respiratory mechanics, not exclusively linked to pre-existing respiratory comorbidities. Lung mechanics parameters were not correlated with oxygenation., Conclusions: Our results suggest that lung mechanics provide complementary information for improving patients phenotyping and personalisation of treatments during NIV in COVID 19 patients, especially in the presence of respiratory comorbidities where deterioration of lung mechanics may be less coupled with changes in oxygenation and more difficult to identify. Oscillometry may provide a valuable tool for monitoring lung mechanics in COVID 19 patients receiving NIV., Competing Interests: Dr Dellaca’ reports grants and other from Restech, personal fees from Philips Healthcare, outside the submitted work. In addition, Dr Dellaca’ has a patent on the detection of EFL by FOT with royalties paid to Philips Respironics and Restech Srl, a patent on monitoring lung volume recruitment by FOT with royalties paid to Vyaire, and a patent on early detection of exacerbations by home monitoring of FOT with royalties paid to Restech and is co-founder and shareholder of Restech Srl, a spin-off company of the Politecnico di Milano University producing medical devices for lung function testing based on FOT. In details: System and methods for the automatic detection of expiratory flow limitation. Application number PCT/EP03/06119. International filing date 10/06/2003. Apparatus for respiratory support and non-invasive detection of alveolar derecruitment for patients suffering from respiratory failure. Application Number: PCT/EP2007/059534, publication date 20/03/2008. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
- Published
- 2022
- Full Text
- View/download PDF